NCT02307942

Brief Summary

The main objective of this study is to compare the efficacy of two weight losing strategies (obesity surgery with gastric banding, and standard of care) on physical performance in elderly obese persons submitted to a physical training. Our hypothesis is that a surgery-induced weight loss in the context of a physical training (which is recommended in people 60-75 yrs losing weight) improves physical performance as compared to standard of care (3-5% weight loss).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Jul 2015

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2014

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 4, 2014

Completed
8 months until next milestone

Study Start

First participant enrolled

July 29, 2015

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2019

Completed
Last Updated

August 28, 2024

Status Verified

August 1, 2024

Enrollment Period

4.4 years

First QC Date

September 16, 2014

Last Update Submit

August 27, 2024

Conditions

Keywords

Randomized Clinical Trialsgastric bandingcalorie restrictionSPPBphysical performanceelderly

Outcome Measures

Primary Outcomes (1)

  • Physical performance

    Short Physical Performance Battery score (SPPB)

    12 months, comparing to the 6 months assesment

Secondary Outcomes (10)

  • Physical performance

    At randomization, 6 and 12 months later

  • weight loss

    At randomization, 6 and 12 months later

  • Composition of weight loss

    At randomization, 6 and 12 months later

  • Changes in muscle strength

    At randomization, 6 and 12 months later

  • Changes in aerobic fitness

    At randomization, 6 and 12 months later

  • +5 more secondary outcomes

Study Arms (2)

SURGERY

EXPERIMENTAL

Patient will be operated for a gastric banding disposal

Procedure: Gastric banding

STANDARD

NO INTERVENTION

Standard of care for obesity

Interventions

The bariatric procedure is a gastric banding under general anesthesia with all the centres using the same surgical procedure (harmonized by group meetings). The laparoscopic surgical procedure has been described. The ERAS protocol will be applied in each centre. The inflation of the band will follow the procedures described by 0'Brien. The patients will attend a group education session before surgery, during which the eating behaviour with a band will be explained and practiced. Then after surgery, the routine procedure is applied.

SURGERY

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Criteria specific to the study Subjects aged 60 or over and younger than 75 yrs., seeking obesity treatments, seeking obesity surgery, with a BMI of 30 kg/m² or more, with comorbidities (see below), and a mildly decreased physical performance (SPPB between 5 and 8) are considered to participate in the study Criteria specific to obesity surgery This projects extends the classical recommendation for obesity surgery to people with a BMI of 30 and over with either the comorbidities list below, or a SPPB between 5 and 8. This level of physical impairment can be considered as a comorbidity in the elderly.
  • The French Ministry of health (HAS) recommends that obesity surgery be considered (here with a gastric banding) in patients fulfilling the following criteria:
  • Subjects with a BMI of 40kg/m² or more, or 35kg/m² or more if at least one comorbidity that can be improved by weight loss is present among hypertension, obstructive sleep apnea, severe metabolic disorder (such as type 2 diabetes, NASH), or rheumatologic conditions associated with disability.
  • After the failure of well designed medical, dietetic, psychological intervention followed up for 6-12 months, with no sufficient weight loss or in case of the failure of maintaining weight loss
  • In subjects well informed of the consequences of surgery, and after a multi-disciplinary evaluation
  • Subjects have understood and accepted the need for a long term medical and surgical follow up
  • The risk of surgery is acceptable
  • patient who signed the informed consent
  • patient affiliated to a social security cover or equivalent

You may not qualify if:

  • Criteria specific to the study
  • These are the impossibility to follow a physical training (unstable coronary heart disease, severe lung function impairment, rheumatologic conditions preventing training, a SPPB score below 5, cancer treatment within the 3 last months, Parkinson's disease, other severe illness that may interfere with physical activity) Criteria specific to gastric banding
  • Cognitive impairment (MMSE ≤ 25)
  • Severe eating disorder
  • Impossible long-term follow-up
  • Alcohol or drug dependence
  • Lack of previous well designed obesity care
  • Vital prognosis engaged in the short term
  • The subject is in jail, or has freedom restriction
  • Guardianship curators or judicial protection
  • Patients participating in another intervention study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Clinique de l'ANJOU

Angers, 49000, France

Location

Hôpital louis Mourier

Colombes, 92701, France

Location

CHU de LILLE

Lille, 59000, France

Location

Hospices Civils de LYON

Lyon, 69495, France

Location

CHU de Nantes

Nantes, 44093, France

Location

HEGP

Paris, 75015, France

Location

CHU de Toulouse

Toulouse, 31059, France

Location

Related Publications (6)

  • Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. doi: 10.1001/jama.292.14.1724.

    PMID: 15479938BACKGROUND
  • Chevallier JM, Zinzindohoue F, Douard R, Blanche JP, Berta JL, Altman JJ, Cugnenc PH. Complications after laparoscopic adjustable gastric banding for morbid obesity: experience with 1,000 patients over 7 years. Obes Surg. 2004 Mar;14(3):407-14. doi: 10.1381/096089204322917954.

    PMID: 15072664BACKGROUND
  • O'Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013 Jan;257(1):87-94. doi: 10.1097/SLA.0b013e31827b6c02.

    PMID: 23235396BACKGROUND
  • Mittermair RP, Obermuller S, Perathoner A, Sieb M, Aigner F, Margreiter R. Results and complications after Swedish adjustable gastric banding-10 years experience. Obes Surg. 2009 Dec;19(12):1636-41. doi: 10.1007/s11695-009-9967-7.

    PMID: 19763708BACKGROUND
  • Chevallier JM, Paita M, Rodde-Dunet MH, Marty M, Nogues F, Slim K, Basdevant A. Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patients' behavior. Ann Surg. 2007 Dec;246(6):1034-9. doi: 10.1097/SLA.0b013e31813e8a56.

    PMID: 18043107BACKGROUND
  • Gagner M, Milone L, Yung E, Broseus A, Gumbs AA. Causes of early mortality after laparoscopic adjustable gastric banding. J Am Coll Surg. 2008 Apr;206(4):664-9. doi: 10.1016/j.jamcollsurg.2007.11.014. Epub 2008 Jan 28.

    PMID: 18387472BACKGROUND

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Patrick RITZ, MD; PhD

    University Hospital of Toulouse, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2014

First Posted

December 4, 2014

Study Start

July 29, 2015

Primary Completion

December 4, 2019

Study Completion

December 4, 2019

Last Updated

August 28, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations